Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+3.04M
-
Total reported value, excl. options
-
$674M
-
Value change
-
+$64.8M
-
Number of buys
-
41
-
Number of sells
-
-39
-
Price
-
$21.59
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2019
97 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q3 2019.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
of 66.4M outstanding shares and own 47.03% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.91M shares), RA CAPITAL MANAGEMENT, L.P. (3.42M shares), JANUS HENDERSON GROUP PLC (3.41M shares), BAKER BROS. ADVISORS LP (2.71M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.59M shares), BlackRock Inc. (1.94M shares), TRV GP, LLC (1.78M shares), FEDERATED INVESTORS INC /PA/ (1.47M shares), VANGUARD GROUP INC (1.28M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.11M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.